logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Manufacturers
    3. Solaris Pharma Corporation

    Solaris Pharma Corporation drugs

    FiltersReset Filters
    11 results

    • clindamycin phosphate

      (clindamycin phosphate)
      Solaris Pharma Corporation
      Usage: Clindamycin phosphate gel, 1%, is indicated for topical treatment of acne vulgaris. Caution is advised due to potential risks of diarrhea and colitis; alternative treatments may be considered.

    • clindamycin phosphate

      (clindamycin phosphate)
      Solaris Pharma Corporation
      Usage: Clindamycin phosphate gel, 1% is indicated for the treatment of acne vulgaris. Physicians should evaluate the risk of diarrhea, bloody diarrhea, and pseudomembranous colitis when considering its use compared to other agents.

    • clindamycin phosphate and tretinoin - clindamycin phosphate and tretinoin gel

      (Clindamycin Phosphate And Tretinoin)
      Solaris Pharma Corporation

    • dicyclomine hydrochloride - dicyclomine hydrochloride tablet

      (Dicyclomine Hydrochloride)
      Solaris Pharma Corporation

    • dicyclomine hydrochloride - dicyclomine hydrochloride capsule

      (Dicyclomine Hydrochloride)
      Solaris Pharma Corporation

    • estradiol

      (ESTRADIOL)
      Solaris Pharma Corporation
      Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy symptoms due to menopause. For vulvar and vaginal atrophy, topical products should be considered first.

    • metronidazole

      (Metronidazole)
      Solaris Pharma Corporation
      Usage: Metronidazole vaginal gel is indicated for treating bacterial vaginosis, characterized by a homogeneous vaginal discharge, elevated pH, fishy odor, and presence of clue cells. Other potential pathogens like Trichomonas vaginalis or Candida albicans should be excluded prior to treatment.

    • moxifloxacin

      (Moxifloxacin Hydrochloride)
      Solaris Pharma Corporation

    • neomycin sulfate - neomycin sulfate tablet

      (Neomycin Sulfate)
      Solaris Pharma Corporation

    • nitroglycerin

      (Nitroglycerin)
      Solaris Pharma Corporation